ZYPREXA Side Effects

7023625-6 | Anal Fissure, Anxiety, Haemorrhoidal Haemorrhage, Nervous System Disorder, Rectal Prolapse, Urinary Hesitation
on Sep 30, 2010 Male patient from UNITED STATES , 14 years of age, weighting 90.00 lb, was treated with Zyprexa (View Usage). Patient experienced the following unwanted or unexpected effects: anal fissure, anxiety (What is anxiety?), haemorrhoidal haemorrhage, nervous system disorder, rectal prolapse, urinary hesitation. Zyprexa dosage: . During the same period patient was treated with INDERAL (View Inderal Review and Inderal Label ), BENADRYL (Benadryl Twice A Day Buccal) (View Benadryl Review and Benadryl Label ), RISPERIDONE (4 Years Twice A Day Buccal) (View Risperidone Review and Risperidone Label ). Patient was hospitalized.

7023160-5 | Aggression, Hypertrichosis, Schizophrenia
Patient was taking Zyprexa (View Usage). Patient had the following side effects: aggression, hypertrichosis, schizophrenia on Sep 30, 2010 from UNITED STATES Additional patient health information: Female patient , 45 years of age, was diagnosed with schizophrenia and. Zyprexa dosage: . Patient was hospitalized.

7022239-1 | Insomnia, Oropharyngeal Pain, Overdose, Paranoia, Visual Acuity Reduced
Adverse event was reported on Sep 17, 2010 by a Female patient taking Zyprexa (View Usage) (Dosage: 30 Mg, Daily (1/d)) was diagnosed with schizophrenia and. Location: UNITED STATES , 46 years of age, After Zyprexa was administered, patient had the following side effects: insomnia, oropharyngeal pain, overdose, paranoia, visual acuity reduced. During the same period patient was treated with MULTI VITAMIN (View Multi-vitamin Review and Multi-vitamin Label ). Patient was hospitalized.

7022238-X | Contusion, Haemorrhagic Diathesis, Platelet Count Decreased
on Sep 17, 2010 Female patient from UNITED STATES , 55 years of age, was treated with Zyprexa (View Usage). Patient experienced the following unwanted or unexpected effects: contusion, haemorrhagic diathesis, platelet count decreased. Zyprexa dosage: 10 Mg, Unk. During the same period patient was treated with DEPAKOTE (View Depakote Review and Depakote Label ), KLONOPIN (View Klonopin Review and Klonopin Label ).


7020304-6 | Agitation, Antisocial Behaviour, Asthenia, Hypersensitivity, Intestinal Haemorrhage, Muscular Weakness, Nervousness, Suicidal Ideation, Yellow Skin
on Sep 16, 2010 Female patient from BRAZIL , 34 years of age, was diagnosed with fear and was treated with Zyprexa (View Usage). Patient had the following side effects: agitation, antisocial behaviour, asthenia, hypersensitivity, intestinal haemorrhage, muscular weakness, nervousness, suicidal ideation, yellow skin. Zyprexa dosage: . During the same period patient was treated with ALPRAZ (View Alpraz Review and Alpraz Label ).

7020302-2 | Abdominal Discomfort, Agitation, Atelectasis, Electrocardiogram Abnormal, Electrocardiogram St Segment Elevation, Electrocardiogram T Wave Inversion, Intentional Overdose, Moaning, Nystagmus
Patient was taking Zyprexa (View Usage). After Zyprexa was administered, patient had the following side effects: abdominal discomfort, agitation, atelectasis, electrocardiogram abnormal, electrocardiogram st segment elevation, electrocardiogram t wave inversion, intentional overdose, moaning, nystagmus on Sep 16, 2010 from UNITED KINGDOM Additional patient health information: Male patient , 40 years of age, was diagnosed with major depression and. Zyprexa dosage: . During the same period patient was treated with AMITRIPTYLINE (View Amitriptyline Review and Amitriptyline Label ), ALIMEMAZINE (View Alimemazine Review and Alimemazine Label ). Patient was hospitalized.

7020295-8 | Cardiac Failure, Off Label Use
Adverse event was reported on Sep 16, 2010 by a Male patient taking Zyprexa (View Usage) (Dosage: 5 Mg, Daily (1/d)) was diagnosed with bipolar disorder (What is bipolar disorder?) and. Location: JAPAN , 57 years of age, Patient experienced the following unwanted or unexpected effects: cardiac failure, off label use. During the same period patient was treated with RISPERDAL (4 Mg, Daily (1/d)) (View Risperdal Review and Risperdal Label ), LIMAS (400 Mg, Daily (1/d)) (View Limas Review and Limas Label ), GOODMIN (0.5 Mg, Daily (1/d)) (View Goodmin Review and Goodmin Label ), ROHYPNOL (4 Mg, Daily (1/d)) (View Rohypnol Review and Rohypnol Label ).

7020290-9 | Insomnia, Malaise, Weight Increased
on Sep 16, 2010 Male patient from UNITED STATES , 42 years of age, weighting 215.0 lb, was treated with Zyprexa (View Usage). Patient had the following side effects: insomnia, malaise, weight increased. Zyprexa dosage: .

7017908-3 | Angle Closure Glaucoma
on Sep 15, 2010 Male patient from FRANCE , 35 years of age, was diagnosed with schizophrenia and was treated with Zyprexa (View Usage). After Zyprexa was administered, patient had the following side effects: angle closure glaucoma. Zyprexa dosage: 10 Mg, Daily (1/d).

7017906-X | Delayed Recovery From Anaesthesia, Surgery
Patient was taking Zyprexa (View Usage). Patient experienced the following unwanted or unexpected effects: delayed recovery from anaesthesia, surgery (What is surgery?) on Sep 15, 2010 from JAPAN Additional patient health information: Male patient , 45 years of age, . Zyprexa dosage: . During the same period patient was treated with LITHIUM CARBONATE (View Lithium Carbonate Review and Lithium Carbonate Label ), AKINETON (View Akineton Review and Akineton Label ).

7017903-4 | Fall
Adverse event was reported on Sep 15, 2010 by a Female patient taking Zyprexa (View Usage) (Dosage: 2.5 Mg, Unk) was diagnosed with bipolar i disorder and. Location: UNITED STATES , 85 years of age, Patient had the following side effects: fall (What is fall?).

7014413-5 | Diabetes Mellitus
on Sep 14, 2010 Female patient from SOUTH AFRICA , 42 years of age, was diagnosed with bipolar disorder (What is bipolar disorder?) and was treated with Zyprexa (View Usage). After Zyprexa was administered, patient had the following side effects: diabetes mellitus. Zyprexa dosage: 10 Mg, Daily (1/d). During the same period patient was treated with ADALAT (30 Mg, Daily (1/d)) (View Adalat Review and Adalat Label ), HYDROCHLOROTHIAZIDE (12.5 Mg, Daily (1/d)) (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ).

7014411-1 | Off Label Use, Wheezing
on Sep 14, 2010 Female patient from UNITED STATES , child 4 years of age, weighting 96.98 lb, was treated with Zyprexa (View Usage). Patient experienced the following unwanted or unexpected effects: off label use, wheezing. Zyprexa dosage: 15 Mg, Unk. During the same period patient was treated with INTUNIV (2 Mg, Unk) (View Intuniv Review and Intuniv Label ), CLARITIN (View Claritin Review and Claritin Label ).

7014394-4 | Leukopenia
Patient was taking Zyprexa (View Usage). Patient had the following side effects: leukopenia on Sep 14, 2010 from AUSTRALIA Additional patient health information: Female patient , 65 years of age, . Zyprexa dosage: .

7014357-9 | Visual Field Defect
Adverse event was reported on Sep 14, 2010 by a Female patient taking Zyprexa (View Usage) (Dosage: Unk, 5 To 10mg Two Times) was diagnosed with psychotic disorder (What is psychotic disorder?) and. Location: AUSTRIA , 30 years of age, After Zyprexa was administered, patient had the following side effects: visual field defect. During the same period patient was treated with LAMOTRIGINE (View Lamotrigine Review and Lamotrigine Label ), CARBAMAZEPINE (View Carbamazepine Review and Carbamazepine Label ), CITALOPRAM HYDROBROMIDE (View Citalopram Hydrobromide Review and Citalopram Hydrobromide Label ).

7012204-2 | Depression, Dizziness, Electrocardiogram Qt Prolonged, Fall, Hypokalaemia, Hyponatraemia, Off Label Use
on Sep 13, 2010 Female patient from GERMANY , 76 years of age, was diagnosed with depression (What is depression?) and was treated with Zyprexa (View Usage). Patient experienced the following unwanted or unexpected effects: depression (What is depression?), dizziness (What is dizziness?), electrocardiogram qt prolonged, fall (What is fall?), hypokalaemia, hyponatraemia, off label use. Zyprexa dosage: 10 Mg, Unk. During the same period patient was treated with CYMBALTA (30-60mg) (View Cymbalta Review and Cymbalta Label ), SOLVEX (8 Mg, Unk) (View Solvex Review and Solvex Label ), LYRICA (25 Mg, Unk) (View Lyrica Review and Lyrica Label ). Patient was hospitalized.

7009306-3 | Alopecia, Blood Glucose Increased, Blood Pressure Increased, Body Fat Disorder, Constipation, Diabetes Mellitus, Dry Mouth, Erectile Dysfunction, Fatigue
on Sep 10, 2010 Male patient from GERMANY , weighting 233.7 lb, was diagnosed with schizophrenia, paranoid type and was treated with Zyprexa (View Usage). Patient had the following side effects: alopecia, blood glucose increased, blood pressure increased, body fat disorder, constipation (What is constipation?), diabetes mellitus, dry mouth, erectile dysfunction (What is erectile dysfunction?), fatigue. Zyprexa dosage: 10 Mg, Daily (1/d). During the same period patient was treated with IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ), PROSTAGUTT /00494901/ (View Prostagutt /00494901/ Review and Prostagutt /00494901/ Label ), CHLORPROTHIXEN (100 Mg, Unk) (View Chlorprothixen Review and Chlorprothixen Label ).

7008613-8 |
Patient was taking Zyprexa (View Usage). on Sep 09, 2010 from UNITED STATES Additional patient health information: Male patient , 25 years of age, . Zyprexa dosage: . During the same period patient was treated with GEODON (View Geodon Review and Geodon Label ).

7008609-6 | Platelet Count Decreased
Adverse event was reported on Sep 09, 2010 by a Female patient taking Zyprexa (View Usage) (Dosage: ) . Location: FRANCE , 62 years of age, Patient experienced the following unwanted or unexpected effects: platelet count decreased.

7005934-X | Back Pain, Blood Creatinine Increased, Depression, Dizziness, Fatigue, Feeling Abnormal, Fluid Retention, Hypertension, Malaise
on Sep 07, 2010 Female patient from UNITED STATES , 49 years of age, was diagnosed with mood altered and was treated with Zyprexa (View Usage). Patient had the following side effects: back pain (What is back pain?), blood creatinine increased, depression (What is depression?), dizziness (What is dizziness?), fatigue, feeling abnormal, fluid retention, hypertension, malaise. Zyprexa dosage: 10 Mg, Daily (1/d). During the same period patient was treated with CELEBREX (View Celebrex Review and Celebrex Label ).

7005928-4 | Epistaxis
on Sep 08, 2010 Male patient from CHILE , 17 years of age, was diagnosed with personality disorder (What is personality disorder?), emergency care and was treated with Zyprexa (View Usage). After Zyprexa was administered, patient had the following side effects: epistaxis. Zyprexa dosage: . During the same period patient was treated with RIVOTRIL (Unk, As Needed) (View Rivotril Review and Rivotril Label ).

7003304-1 | Abnormal Behaviour, Aphasia, Asthenia, Coma, Endotracheal Intubation, Hallucination, Intentional Overdose, Masked Facies, Muscle Rigidity
Patient was taking Zyprexa (View Usage). Patient experienced the following unwanted or unexpected effects: abnormal behaviour, aphasia (What is aphasia?), asthenia, coma, endotracheal intubation, hallucination, intentional overdose, masked facies, muscle rigidity on Sep 07, 2010 from UNITED STATES Additional patient health information: Female patient , 56 years of age, was diagnosed with bipolar disorder (What is bipolar disorder?) and. Zyprexa dosage: . During the same period patient was treated with GEODON (View Geodon Review and Geodon Label ), SEROQUEL (View Seroquel Review and Seroquel Label ). Patient was hospitalized.

7003288-6 | Basedow's Disease, Hepatic Steatosis, Hyperinsulinaemia, Hyperprolactinaemia, Obesity
Adverse event was reported on Sep 07, 2010 by a Female patient taking Zyprexa (View Usage) (Dosage: 5 Mg, Daily (1/d)) was diagnosed with schizophrenia and. Location: JAPAN , weighting 187.6 lb, Patient had the following side effects: basedow's disease, hepatic steatosis, hyperinsulinaemia, hyperprolactinaemia, obesity (What is obesity?). During the same period patient was treated with DORAL (15 Mg, Daily (1/d)) (View Doral Review and Doral Label ), RISPERDAL (3 Mg, Daily (1/d)) (View Risperdal Review and Risperdal Label ), LEVOTOMIN (5 Mg, Daily (1/d)) (View Levotomin Review and Levotomin Label ).

6994571-9 | Extrapyramidal Disorder, Fall, Subdural Haematoma
on Sep 16, 2010 Female patient from UNITED STATES , 73 years of age, weighting 148.8 lb, was diagnosed with major depression and was treated with Zyprexa (View Usage). After Zyprexa was administered, patient had the following side effects: extrapyramidal disorder, fall (What is fall?), subdural haematoma. Zyprexa dosage: . During the same period patient was treated with AVALIDE (View Avalide Review and Avalide Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), DEPAKOTE (View Depakote Review and Depakote Label ), SERTRALINE HYDROCHLORIDE (View Sertraline Hydrochloride Review and Sertraline Hydrochloride Label ), XALATAN (View Xalatan Review and Xalatan Label ), COMBIGAN (View Combigan Review and Combigan Label ), TIMOLOL (View Timolol Review and Timolol Label ), XANAX (View Xanax Review and Xanax Label ).

6994276-4 | Agitation, Insomnia
on Sep 07, 2010 Female patient from SWITZERLAND , 31 years of age, weighting 156.5 lb, was treated with Zyprexa (View Usage). Patient experienced the following unwanted or unexpected effects: agitation, insomnia. Zyprexa dosage: Unk Mg,. During the same period patient was treated with LEPONEX (12.5 Mg, 2/d) (View Leponex Review and Leponex Label ).

6990103-X | Abdominal Discomfort, Agitation, Electrocardiogram Abnormal, Electrocardiogram St Segment Elevation, Electrocardiogram T Wave Inversion, Intentional Overdose, Moaning, Nystagmus, Sinus Tachycardia
Patient was taking Zyprexa (View Usage). Patient had the following side effects: abdominal discomfort, agitation, electrocardiogram abnormal, electrocardiogram st segment elevation, electrocardiogram t wave inversion, intentional overdose, moaning, nystagmus, sinus tachycardia on Sep 03, 2010 from UNITED KINGDOM Additional patient health information: Male patient , 40 years of age, . Zyprexa dosage: . During the same period patient was treated with AMITRIPTYLINE HCL (View Amitriptyline Hcl Review and Amitriptyline Hcl Label ), ALIMEMAZINE (View Alimemazine Review and Alimemazine Label ). Patient was hospitalized.

6988548-7 | Ataxia, Blood Chloride Decreased, Blood Potassium Decreased, Blood Sodium Decreased, Delirium, Haematocrit Decreased, Haemoglobin Decreased, Psychotic Disorder
Adverse event was reported on Sep 03, 2010 by a Female patient taking Zyprexa (View Usage) (Dosage: 5 Mg, 2/d) was diagnosed with hallucination, blood pressure (What is blood pressure?), hypertension, diabetes mellitus, depression (What is depression?), parkinson's disease (What is parkinson's disease?), prophylaxis and. Location: UNITED STATES , weighting 152.0 lb, After Zyprexa was administered, patient had the following side effects: ataxia (What is ataxia?), blood chloride decreased, blood potassium decreased, blood sodium decreased, delirium, haematocrit decreased, haemoglobin decreased, psychotic disorder (What is psychotic disorder?). During the same period patient was treated with CARDIAZEM (View Cardiazem Review and Cardiazem Label ), LOVASTATIN (View Lovastatin Review and Lovastatin Label ), METFORMIN (View Metformin Review and Metformin Label ), AMITRIPTYLINE HCL (View Amitriptyline Hcl Review and Amitriptyline Hcl Label ), STALEVO 100 (View Stalevo 100 Review and Stalevo 100 Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), VITAMIN B 12 (View Vitamin B-12 Review and Vitamin B-12 Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ). Patient was hospitalized.

6985193-4 | Aplasia Pure Red Cell, Hepatic Fibrosis, Hepatitis Cholestatic, Hypersensitivity, Liver Injury, Lung Infection, Lymphadenopathy, Mycoplasma Infection, Pleural Effusion
on Sep 14, 2010 Female patient from UNITED STATES , 19 years of age, was treated with Zyprexa (View Usage). Patient experienced the following unwanted or unexpected effects: aplasia pure red cell, hepatic fibrosis, hepatitis cholestatic, hypersensitivity, liver injury, lung infection, lymphadenopathy, mycoplasma infection, pleural effusion. Zyprexa dosage: . During the same period patient was treated with Z PAK (AZITHROMYCIN) (View Z-pak (azithromycin) Review and Z-pak (azithromycin) Label ).

6984955-7 | Lung Neoplasm Malignant, Overdose
on Sep 02, 2010 Female patient from NEW ZEALAND , 53 years of age, was diagnosed with schizophrenia and was treated with Zyprexa (View Usage). Patient had the following side effects: lung neoplasm malignant, overdose. Zyprexa dosage: 7.5 Mg, Each Morning. During the same period patient was treated with LITHIUM CARBONATE (View Lithium Carbonate Review and Lithium Carbonate Label ), VALPROATE SODIUM (View Valproate Sodium Review and Valproate Sodium Label ).

6984948-X | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Lactate Dehydrogenase Increased, Off Label Use, Rhabdomyolysis
Patient was taking Zyprexa (View Usage). After Zyprexa was administered, patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood lactate dehydrogenase increased, off label use, rhabdomyolysis on Sep 02, 2010 from SWEDEN Additional patient health information: Male patient , 34 years of age, was diagnosed with mental disorder and. Zyprexa dosage: 5 Mg, Daily (1/d).

6984945-4 | Venous Thrombosis Limb
Adverse event was reported on Sep 02, 2010 by a Male patient taking Zyprexa (View Usage) (Dosage: 10 Mg, Daily (1/d)) . Location: SWEDEN , 47 years of age, Patient experienced the following unwanted or unexpected effects: venous thrombosis limb. During the same period patient was treated with CITALOPRAM HYDROBROMIDE (View Citalopram Hydrobromide Review and Citalopram Hydrobromide Label ), TRILAFON (View Trilafon Review and Trilafon Label ), BETNOVATE (View Betnovate Review and Betnovate Label ), LITHIONIT (View Lithionit Review and Lithionit Label ), TIMOSAN (View Timosan Review and Timosan Label ).

6984940-5 | Blood Glucose Abnormal, Glucose Tolerance Impaired, Liver Disorder, Proctitis
on Sep 03, 2010 Female patient from JAPAN , weighting 78.48 lb, was diagnosed with schizophrenia, proctitis and was treated with Zyprexa (View Usage). Patient had the following side effects: blood glucose abnormal, glucose tolerance impaired, liver disorder, proctitis. Zyprexa dosage: 20 Mg, Daily (1/d). During the same period patient was treated with ABILIFY (6 Mg, Daily (1/d)) (View Abilify Review and Abilify Label ), LENDEM (0.25 Mg, Daily (1/d)) (View Lendem Review and Lendem Label ), ROHYPNOL (2 Mg, Daily (1/d)) (View Rohypnol Review and Rohypnol Label ), STERONEMA (1 D/f, Daily (1/d)) (View Steronema Review and Steronema Label ), ULCERLMIN (2 D/f, Daily (1/d)) (View Ulcerlmin Review and Ulcerlmin Label ), MINOPHAGEN C (2 D/f, Daily (1/d)) (View Minophagen C Review and Minophagen C Label ). Patient was hospitalized.

6984898-9 | Mental Disorder, Overdose, Thrombosis
on Sep 02, 2010 Male patient from AUSTRIA , 37 years of age, weighting 149.9 lb, was diagnosed with anxiety (What is anxiety?) and was treated with Zyprexa (View Usage). After Zyprexa was administered, patient had the following side effects: mental disorder, overdose, thrombosis. Zyprexa dosage: 30 Mg, Daily (1/d). During the same period patient was treated with ESCITALOPRAM (20 Mg, Daily (1/d)) (View Escitalopram Review and Escitalopram Label ). Patient was hospitalized.

6984897-7 |
Patient was taking Zyprexa (View Usage). on Sep 03, 2010 from FRANCE Additional patient health information: Male patient , 45 years of age, . Zyprexa dosage: . During the same period patient was treated with HYPNOTICS AND SEDATIVES (View Hypnotics And Sedatives Review and Hypnotics And Sedatives Label ), NICOTINE (View Nicotine Review and Nicotine Label ).

6984894-1 | Cerebrovascular Accident, Intracranial Aneurysm, Pneumonia, Pyrexia, Urinary Tract Infection
Adverse event was reported on Sep 02, 2010 by a Male patient taking Zyprexa (View Usage) (Dosage: ) . Location: BRAZIL , 83 years of age, Patient had the following side effects: cerebrovascular accident, intracranial aneurysm, pneumonia (What is pneumonia?), pyrexia, urinary tract infection (What is urinary tract infection?). Patient was hospitalized.

6984893-X | Thrombocytopenia
on Sep 02, 2010 Male patient from FINLAND , 75 years of age, was treated with Zyprexa (View Usage). After Zyprexa was administered, patient had the following side effects: thrombocytopenia. Zyprexa dosage: 5 Mg, Unk. During the same period patient was treated with SIRDALUD (View Sirdalud Review and Sirdalud Label ). Patient was hospitalized.

6984887-4 | Abnormal Behaviour, Completed Suicide, Hallucination, Auditory
on Sep 03, 2010 Male patient from BRAZIL , 59 years of age, was diagnosed with psychotic disorder (What is psychotic disorder?), major depression and was treated with Zyprexa (View Usage). Patient experienced the following unwanted or unexpected effects: abnormal behaviour, completed suicide, hallucination, auditory. Zyprexa dosage: . During the same period patient was treated with ESCITALOPRAM (View Escitalopram Review and Escitalopram Label ).

6980260-3 | Asthenia, Hypersensitivity, Intestinal Haemorrhage, Muscular Weakness, Yellow Skin
Patient was taking Zyprexa (View Usage). Patient had the following side effects: asthenia, hypersensitivity, intestinal haemorrhage, muscular weakness, yellow skin on Sep 01, 2010 from BRAZIL Additional patient health information: Female patient , 34 years of age, . Zyprexa dosage: .

6978238-9 | Platelet Count Decreased
Adverse event was reported on Aug 31, 2010 by a Female patient taking Zyprexa (View Usage) (Dosage: 20 Mg, Unk) was diagnosed with schizophrenia and. Location: JAPAN , 63 years of age, After Zyprexa was administered, patient had the following side effects: platelet count decreased. During the same period patient was treated with MEVATORTE (View Mevatorte Review and Mevatorte Label ), VESICARE (View Vesicare Review and Vesicare Label ).

6978234-1 | Off Label Use, Stress
on Aug 31, 2010 Female patient from SWITZERLAND , 34 years of age, was diagnosed with personality disorder (What is personality disorder?), mineral supplementation and was treated with Zyprexa (View Usage). Patient experienced the following unwanted or unexpected effects: off label use, stress (What is stress?). Zyprexa dosage: 5 Mg, One Time. During the same period patient was treated with IRON (View Iron Review and Iron Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ). Patient was hospitalized.

6978214-6 | Dyspnoea, Liver Injury, Multi-organ Failure, Overdose, Pyrexia
on Aug 31, 2010 Male patient from GREECE , 46 years of age, was diagnosed with schizophrenia and was treated with Zyprexa (View Usage). Patient had the following side effects: dyspnoea, liver injury, multi-organ failure, overdose, pyrexia. Zyprexa dosage: 15 Mg, 2/d. Patient was hospitalized.

6978210-9 | Hyponatraemia, Rhabdomyolysis
Patient was taking Zyprexa (View Usage). After Zyprexa was administered, patient had the following side effects: hyponatraemia, rhabdomyolysis on Aug 31, 2010 from NORWAY Additional patient health information: Male patient , 47 years of age, . Zyprexa dosage: .

6975872-7 | Hospitalisation, Overdose, Pulmonary Embolism
Adverse event was reported on Aug 30, 2010 by a Female patient taking Zyprexa (View Usage) (Dosage: 5 Mg, Each Morning) was diagnosed with bipolar disorder (What is bipolar disorder?) and. Location: UNITED STATES , 61 years of age, Patient experienced the following unwanted or unexpected effects: hospitalisation, overdose, pulmonary embolism (What is pulmonary embolism?). During the same period patient was treated with LITHIUM CARBONATE (300 Mg, Each Morning) (View Lithium Carbonate Review and Lithium Carbonate Label ). Patient was hospitalized.

6975871-5 | Altered State Of Consciousness, Atrioventricular Block, Labile Blood Pressure
on Aug 30, 2010 Female patient from JAPAN , 75 years of age, was diagnosed with schizophrenia, hypertension, insomnia and was treated with Zyprexa (View Usage). Patient had the following side effects: altered state of consciousness, atrioventricular block, labile blood pressure. Zyprexa dosage: 2.5 Mg~5.0mg, Daily (1/d). During the same period patient was treated with DIOVAN (40 Mg, Daily (1/d)) (View Diovan Review and Diovan Label ), AMLODIPINE BESYLATE (20 Mg, Daily (1/d)) (View Amlodipine Besylate Review and Amlodipine Besylate Label ), SILECE (View Silece Review and Silece Label ).

6975866-1 | Aggression, Hypertrichosis, Schizophrenia
on Aug 30, 2010 Female patient from UNITED STATES , 45 years of age, was diagnosed with schizophrenia and was treated with Zyprexa (View Usage). After Zyprexa was administered, patient had the following side effects: aggression, hypertrichosis, schizophrenia. Zyprexa dosage: . Patient was hospitalized.

6975856-9 | Decreased Appetite, Dehydration, Heat Stroke, Hyperthermia Malignant, Liver Injury, Loss Of Consciousness, Rhabdomyolysis, Supraventricular Tachycardia
Patient was taking Zyprexa (View Usage). Patient experienced the following unwanted or unexpected effects: decreased appetite, dehydration, heat stroke, hyperthermia malignant, liver injury, loss of consciousness, rhabdomyolysis, supraventricular tachycardia on Aug 30, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 208.0 lb, was diagnosed with bipolar disorder (What is bipolar disorder?), mood altered, anxiety (What is anxiety?), headache (What is headache?) and. Zyprexa dosage: 20 Mg, Daily (1/d). During the same period patient was treated with FLUOXETINE HYDROCHLORIDE (20 Mg, Daily (1/d)) (View Fluoxetine Hydrochloride Review and Fluoxetine Hydrochloride Label ), CLONAZEPAM (1 Mg, As Needed) (View Clonazepam Review and Clonazepam Label ), MIDRIN (Unk, As Needed) (View Midrin Review and Midrin Label ), ETHANOL (View Ethanol Review and Ethanol Label ), METHAMPHETAMINE (View Methamphetamine Review and Methamphetamine Label ), CANNABIS (View Cannabis Review and Cannabis Label ), AMPHETAMINE AND DEXTROAMPHETAMINE SALTS (View Amphetamine And Dextroamphetamine Salts Review and Amphetamine And Dextroamphetamine Salts Label ). Patient was hospitalized and became disabled.

6972978-3 | Anxiety, Ewing's Sarcoma, Food Intolerance, Nausea, Oesophagitis, Retching, Stress
Adverse event was reported on Aug 26, 2010 by a Male patient taking Zyprexa (View Usage) (Dosage: 2.5 Mg, Each Evening) was diagnosed with depression (What is depression?) and. Location: UNITED STATES , 19 years of age, Patient had the following side effects: anxiety (What is anxiety?), ewing's sarcoma, food intolerance, nausea (What is nausea?), oesophagitis, retching, stress (What is stress?). During the same period patient was treated with KLONOPIN (View Klonopin Review and Klonopin Label ).

6972824-8 | Bundle Branch Block Right, Electrocardiogram Qt Prolonged
on Aug 27, 2010 Male patient from GERMANY , 65 years of age, was treated with Zyprexa (View Usage). After Zyprexa was administered, patient had the following side effects: bundle branch block right, electrocardiogram qt prolonged. Zyprexa dosage: . During the same period patient was treated with LORAZEPAM (1.5 Mg, Unk) (View Lorazepam Review and Lorazepam Label ). Patient was hospitalized.

6972823-6 | Overdose, Thrombosis
on Aug 27, 2010 Male patient from AUSTRIA , 37 years of age, weighting 149.9 lb, was diagnosed with anxiety (What is anxiety?) and was treated with Zyprexa (View Usage). Patient experienced the following unwanted or unexpected effects: overdose, thrombosis. Zyprexa dosage: 30 Mg, Daily (1/d). During the same period patient was treated with ESCITALOPRAM (20 Mg, Daily (1/d)) (View Escitalopram Review and Escitalopram Label ). Patient was hospitalized.

6972822-4 | Epistaxis
Patient was taking Zyprexa (View Usage). Patient had the following side effects: epistaxis on Aug 27, 2010 from AUSTRALIA Additional patient health information: Female patient , 30 years of age, . Zyprexa dosage: 10 Mg, Daily (1/d). During the same period patient was treated with VALPROATE SODIUM (View Valproate Sodium Review and Valproate Sodium Label ), SEROQUEL (View Seroquel Review and Seroquel Label ), VITAMIN D (View Vitamin D Review and Vitamin D Label ).